Literature DB >> 21681384

Update on pathophysiology and treatment of hypertension in the elderly.

Debbie L Cohen1, Raymond R Townsend.   

Abstract

Hypertension is common in the elderly, and its prevalence increases with aging. The vascular system is a prototypical aging tissue, and arterial stiffness plays a major role in hypertension as the individual ages. Some unique aging changes in the nitric oxide and angiotensin II pathways are particularly important for vascular aging. Studies focusing on direct measures of vascular stiffness have increased understanding of the pathophysiology behind increased arterial stiffness. Goal blood pressure in the elderly is debated, but based on current outcome data, a goal blood pressure of 150/80-90 mm Hg is reasonable in at least the very elderly. This review discusses in detail the various landmark hypertension studies in the elderly. We recommend use of thiazide diuretics, long-acting calcium channel blockers, and angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers as either monotherapy or in combination, with beta-blockers reserved for patients with specific indications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681384     DOI: 10.1007/s11906-011-0215-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  56 in total

1.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

Authors:  L Liu; J G Wang; L Gong; G Liu; J A Staessen
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

2.  Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.

Authors:  Mingyi Wang; Jing Zhang; Gaia Spinetti; Li-Qun Jiang; Robert Monticone; Di Zhao; Linda Cheng; Melissa Krawczyk; Mark Talan; Gianfranco Pintus; Edward G Lakatta
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Impact of electrocardiographic left ventricular hypertrophy on the occurrence of cardiovascular events in elderly hypertensive patients. - The Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) -.

Authors:  Satoshi Jissho; Kenei Shimada; Haruyuki Taguchi; Ken Yoshida; Shota Fukuda; Hidemasa Tanaka; Junichi Yoshikawa; Minoru Yoshiyama; Masao Ishii; Yoshio Goto
Journal:  Circ J       Date:  2010-03-26       Impact factor: 2.993

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group.

Authors: 
Journal:  J Hypertens       Date:  1985-08       Impact factor: 4.844

7.  Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities.

Authors:  R Virmani; A P Avolio; W J Mergner; M Robinowitz; E E Herderick; J F Cornhill; S Y Guo; T H Liu; D Y Ou; M O'Rourke
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

8.  Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia.

Authors:  Y Nagai; E J Metter; C J Earley; M K Kemper; L C Becker; E G Lakatta; J L Fleg
Journal:  Circulation       Date:  1998-10-13       Impact factor: 29.690

Review 9.  Arterial aging: a journey into subclinical arterial disease.

Authors:  Mingyi Wang; Robert E Monticone; Edward G Lakatta
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

Review 10.  Mechanical factors in arterial aging: a clinical perspective.

Authors:  Michael F O'Rourke; Junichiro Hashimoto
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

View more
  14 in total

Review 1.  Arterial stiffness: basic concepts and measurement techniques.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2012-03-24       Impact factor: 4.132

2.  The effect of slow-loaded breathing training on the blood pressure response to handgrip exercise in patients with isolated systolic hypertension.

Authors:  Chulee Ubolsakka-Jones; Benjarat Sangthong; Wilaiwan Khrisanapant; David A Jones
Journal:  Hypertens Res       Date:  2017-04-20       Impact factor: 3.872

Review 3.  Noninvasive arterial compliance estimation.

Authors:  D Švec; M Javorka
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

Review 4.  Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.

Authors:  Stefano Omboni; Ettore Malacco; Jean-Michel Mallion; Paolo Fabrizzi; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-17

5.  Association of age and admission mean arterial blood pressure in patients with stroke-data from a national stroke registry.

Authors:  Yoav Eizenberg; Silvia Koton; David Tanne; Ehud Grossman
Journal:  Hypertens Res       Date:  2016-01-07       Impact factor: 3.872

6.  Changes of imidazoline receptors in spontaneously hypertensive rats.

Authors:  Guang-Yuan Mar; Ming-Ting Chou; Hsien-Hui Chung; Nien-Hua Chiu; Mei-Fen Chen; Juei-Tang Cheng
Journal:  Int J Exp Pathol       Date:  2012-11-24       Impact factor: 1.925

Review 7.  Antihypertensive withdrawal for the prevention of cognitive decline.

Authors:  Susan Jongstra; Jennifer K Harrison; Terry J Quinn; Edo Richard
Journal:  Cochrane Database Syst Rev       Date:  2016-11-01

Review 8.  Essential hypertension: an approach to its etiology and neurogenic pathophysiology.

Authors:  Juan J Bolívar
Journal:  Int J Hypertens       Date:  2013-12-09       Impact factor: 2.420

Review 9.  The treatment of hypertension in people with dementia: a systematic review of observational studies.

Authors:  Tomas J Welsh; John R Gladman; Adam L Gordon
Journal:  BMC Geriatr       Date:  2014-02-12       Impact factor: 3.921

10.  Characterization of imidazoline receptors in blood vessels for the development of antihypertensive agents.

Authors:  Mei-Fen Chen; Jo-Ting Tsai; Li-Jen Chen; Tung-Pi Wu; Jia-Jang Yang; Li-Te Yin; Yu-Lin Yang; Tai-An Chiang; Han-Lin Lu; Ming-Chang Wu
Journal:  Biomed Res Int       Date:  2014-04-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.